THURSDAY, May 1, 2025 (HealthDay News) — A well-known U.S. science journal focused on environmental health has stopped accepting new studies, raising alarms among researchers who rely on it heavily. Environmental Health Perspectives (EHP), a journal funded by the National Institutes of Health (NIH), announced that it would pause newContinue Reading

THURSDAY, May 1, 2025 (HealthDay News) — The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found. Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ — 63%, compared with 34% ofContinue Reading